SEP 27, 2016 05:50 PM PDT

Iron Nanoparticles Reign in the Immune Attack on Cancer

WRITTEN BY: Kara Marker
Scientists from Stanford University accidentally discovered a new cancer treatment, and it’s got all of the anti-cancer capabilities of chemotherapy without any of the toxic side effects. 
Researchers were studying the potential of iron nanoparticles to deliver chemotherapy into mice with tumors when they realized that the nanoparticles alone had anti-cancer properties. The original experimental group of mice received nanoparticles packed with chemotherapy, to be compared to two control groups: mice receiving “empty” nanoparticles with no chemotherapy and mice receiving neither nanoparticles nor chemotherapy.

Their results showed a reduction in tumor growth in mice that received the empty nanoparticles compared to the other control group, and the researchers realized that they had inadvertently discovered anti-cancer properties of iron nanoparticles. 

Iron nanoparticles already exist as FDA-approved iron supplements that are commercially available as “ferumoxytol.” They are currently used as an injection to treat iron-deficiency anemia in adults with chronic kidney disease, working to restore iron levels so the body can make more red blood cells. However, as seen in the present study, researchers like senior author Heike Daldrup-Link, MD, are realizing that iron nanoparticles “may have hidden intrinsic effects that we won't appreciate unless we look at the nanoparticles themselves."

After the researchers initially realized the anti-cancer ability of ferumoxytol, they conducted further studies to get a clearer picture of how the nanoparticles were reducing tumor growth. They found that ferumoxytol prompts tumor-associated macrophages (TAMs) to destroy cancer cells in mice, and they believe that it works the same way in human as well.

While TAMs are already designed to contain anti-cancer abilities, but large tumors can inhibit their activity. Iron nanoparticles work by rebooting the ability of TAMs to recognize and attack cancer cells. In fact, without TAMs, nanoparticles would have no anti-cancer qualities. 

The researchers continued with studies of mice models of both breast cancer and small-cell lung cancer, proving respectively that one dose of ferumoxytol inhibits tumor growth for up to three weeks and limits metastasis in the liver.  

Because ferumoxytol is already approved by the FDA, the transition from animal studies to human clinical trials is likely to be speedier than normal. Ferumoxytol has the potential to complement existing cancer treatments such as immunotherapy, radiation, chemotherapy, and surgery. Plus, since the iron nanoparticles lack the toxic side effects present during chemotherapy, they could be used to treat patients in the vulnerable period after surgery to remove tumor masses.

"We think this could bridge the time when the patient is quite sick after surgery, and help keep the cancer from spreading until they are able to receive chemotherapy," Daldrup-Link said. "If there are some tumor cells left after surgery, it might work to inject iron nanoparticles there, and the smaller tumor seeds could potentially be taken care of by our immune system.”

The study was recently published in the journal Nature Nanotechnology
 


Sources: Stanford University School of Medicine, MedlinePlus
Image: Amy Thomas
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Impact of Ankylosing Spondylitis on Quality of Life
  Ankylosing spondylitis (AS) is a chronic inflammatory disease that most often affects the sacroiliac (SI) joints and axial skeleton (see figure abov...
SEP 17, 2019
Immunology
SEP 17, 2019
Silent Inflammation, the Silent Problem
People who have chronic inflammation in middle-age may develop problems with thinking and memory...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Dietary Cholesterol and Its Impact on Autoimmune and Infectious Disease Processes
There has been a great deal of media coverage and controversy over the role of diet on disease processes such as autoimmunity and infection. Can dietary ch...
SEP 17, 2019
Drug Discovery
SEP 17, 2019
Combination Immunotherapy Stops Liver Cancer Growth
The number of individuals diagnosed with liver cancer is on the rise and current therapies are largely ineffective. However, new preclinical data from the ...
SEP 17, 2019
Genetics & Genomics
SEP 17, 2019
Smoking Dads Alter Immune Gene Epigenetics & Increase Risk of Asthma in Kids
Using a group of 1,629 couples, scientists in Taiwan have analyzed the impact of paternal smoking on children....
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Diagnosis and Treatment of Neurosarcoidosis
Sarcoidosis is a multisystem inflammatory disease characterized by the formation of non-caseating granulomas in the affected organs. The majority of p...
Loading Comments...